Cardiol Therapeutics Inc. (CRDL)
1.23
-0.02 (-1.60%)
At close: Jan 15, 2025, 9:54 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | n/a | 78.76K | n/a | n/a | n/a | n/a |
| Cost of Revenue | 248.35K | 219.91K | n/a | 229.54K | 150.57K | 91.49K | 53.34K |
| Gross Profit | -248.35K | -219.91K | 78.76K | -229.54K | -150.57K | -91.49K | -53.34K |
| Operating Income | -29.79M | -50.34M | -45.47M | -20.61M | -13.58M | -7.39M | -1.59M |
| Interest Income | 2.04K | 1.24M | 106.00K | 76.58K | 245.42K | 103.31K | 6.12K |
| Pretax Income | -28.13M | -30.93M | -31.64M | -20.64M | -13.68M | -15.89M | -1.66M |
| Net Income | -28.13M | -30.93M | -31.64M | -20.64M | -13.68M | -15.89M | -1.66M |
| Selling & General & Admin | 15.56M | 22.37M | 27.87M | 9.95M | 10.45M | 5.87M | 1.10M |
| Research & Development | 14.22M | 18.96M | 10.87M | 10.52M | 3.53M | 1.53M | 441.26K |
| Other Expenses | 0.00 | 164.44K | 112.23K | 7.40K | 298.80K | n/a | -60.56K |
| Operating Expenses | 29.79M | 41.34M | 38.74M | 20.69M | 14.13M | 7.49M | 1.60M |
| Interest Expense | n/a | n/a | n/a | n/a | 621.00 | 663.37K | 60.56K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 29.79M | 41.34M | 38.74M | 20.69M | 14.13M | 7.49M | 1.60M |
| Income Tax | n/a | -10.24M | -6.91M | 7.40K | 299.42K | 663.37K | 60.56K |
| Shares Outstanding (Basic) | 64.46M | 62.51M | 43.22M | 29.86M | 25.82M | 15.37M | 22.71M |
| Shares Outstanding (Diluted) | 64.46M | 62.51M | 43.22M | 29.86M | 25.82M | 15.37M | 22.71M |
| EPS (Basic) | -0.44 | -0.49 | -0.73 | -0.69 | -0.53 | -1.03 | -0.07 |
| EPS (Diluted) | -0.44 | -0.49 | -0.73 | -0.69 | -0.53 | -1.03 | -0.07 |
| EBITDA | -29.59M | -41.16M | -38.44M | -20.46M | -11.77M | -7.30M | -1.50M |
| Depreciation & Amortization | 195.26K | 219.91K | 220.42K | 229.54K | 150.57K | 91.49K | 53.34K |